Lung Cancer
Commentary
‘We Need to Rethink Our Options’: Lung Cancer Recurrence
“Suddenly, we have better tools to control systemic spread.”
News
Why Lung Cancer Screening Is Not for Everyone
Many participants in a survey were unaware that further imaging or other types of tests could follow LDCT.
News
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
Researchers assess validity of the molecular targets and clinical benefits of genome-targeted cancer drugs approved in the United States from 2015...
Conference Coverage
No Routine Cancer Screening Option? New MCED Tests May Help
CanScan, MERCURY, and OncoSeek can detect a range of cancers and recognize the tissue of origin with high accuracy.
News
Oncologists Voice Ethical Concerns Over AI in Cancer Care
Researchers ask 204 oncologists from 37 states for their views on the ethical implications of using AI for cancer care.
Conference Coverage
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.
News
Virtual Reality Brings Relief to Hospitalized Patients With Cancer
Patients were randomized to receive either 10 minutes of immersive VR distraction therapy or 10 minutes of two-dimensional guided imagery...
News
Should Opioids Be Used for Chronic Cancer Pain?
Prescribing strategies are partly driven by peer pressure, new research suggests.
Commentary
A Banned Chemical That Is Still Causing Cancer
This carcinogen ‘is still around: in our soil, in our food, and in our blood.’
Latest News
Lung Cancer Vaccine Gets Injection of Funding for Research and Development
Using technology based on Oxford’s COVID-19 vaccine, researchers will use funding to develop and test a potential lung cancer vaccine.